The dearth of experienced professionals is exacerbating the pressure on LPs who are dealing with a crush of new funds in market, and re-up requests at unprecedented rates.
The $46bn medical research endowment wants to be aligned with GPs who roll over and compound their exposure to assets rather than those who sell down, Robert Coke, head of buyout and residential property, tells PEI.
While partner departures are generally viewed with concern by LPs, in this case the three individuals leaving represent a kind of “changing of the guard” at the firm.
Of primary interest will be high-growth tech businesses that prove their mettle 'as the tide goes out,' Leon Pedersen, CPPIB's new head of growth equity, told Buyouts.